Q1 FY27 Results: Revenue up 22%, PAT jumps 219% YoY

Revenue Growth 20pctPat Growth 25pctResults RestatedResults View source PDF Explain this filing

JASH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹509.50

prior close

₹519.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-1.7% vs market

Industrial Products peers, median of 131sector-0.3%-1.5% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.5 pts less than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.9

10m

-1.3

15m

-3.4

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9-0.2-1.7-0.3-1.5

Next day

-2.7+0.2-2.9-0.5-2.3

-4.9+0.4-5.3-0.5-4.4

-3.6+0.4-4.1-0.6-3.0

-5.6+0.6-6.1-1.7-3.9

-6.2+0.9-7.1-1.3-4.9

-5.0+0.9-5.9-0.8-4.2

15d

-10.7+0.9-11.6-2.4-8.2

+1.1+2.3-1.3-0.3+1.4

+11.2-1.1+12.3-1.8+13.0

—————

UpDownMarket · Nifty Microcap 250Sector · Industrial Products peers, median of 131Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jash Engineering Q1 FY27 standalone revenue rose to Rs 98.3 crore, up 21.8% from Rs 80.7 crore YoY. Standalone PAT surged to Rs 13.4 crore from Rs 4.2 crore, up 219% YoY. Consolidated revenue grew to Rs 149.9 crore with PAT at Rs 5.1 crore versus a loss last year. Board approved MD Pratik Patel's reappointment for 5 years from March 2027, authorized ESOP 2019 amendments to extend grants, set 52nd AGM for Sept 23 2026, and appointed M P Turakhia as Cost Auditor. Auditor Deloitte gave a clean limited review.

Likely market impact

Strong profit growth signals healthy demand and operational efficiency. MD continuity offers leadership stability; ESOP amendments may dilute equity slightly.